Reuters logo
5 months ago
BRIEF-A1M Pharma: ROSGard shows strong protective effect against renal damage in connection with radiation therapy in preclinical long-term study
March 29, 2017 / 12:44 PM / 5 months ago

BRIEF-A1M Pharma: ROSGard shows strong protective effect against renal damage in connection with radiation therapy in preclinical long-term study

March 29 (Reuters) - A1M PHARMA AB:

* PRELIMINARY DATA FROM THE COMPLETED PRECLINICAL LONG-TERM STUDY WITH AN ANIMAL MODEL CLEARLY ESTABLISH THE STRONG PROTECTIVE EFFECT AGAINST RENAL DAMAGE OF THE ACTIVE SUBSTANCE IN THE CANDIDATE DRUG ROSGARD IN CONNECTION WITH RADIATION THERAPY

* CLINICAL STUDIES ARE SCHEDULED TO START IN THE BEGINNING OF 2018

Source text: bit.ly/2mPzCgw

Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below